Project Grant K01HL188570
Award Date 9/1/26
Completion Date 6/30/30
Dollars Obligated $175K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Riverside, East Providence, RI 02915, USA
Similar Awards
- The National Heart Lung and Blood Institute (NHLBI) awarded the University of South Carolina $100,000 on September 1, 2026, under the Trans-NIH Research Support program (CFDA 93.310) to conduct a randomized controlled trial evaluating a prevention-focused behavioral sleep intervention for parents of preschool-aged children. The study will enroll 198 parent-child dyads (children ages 2–4 years with insufficient sleep at baseline and no reported sleep disorder) and randomize them to receive either...
- The National Heart, Lung, and Blood Institute awarded Yale University $839,771 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 1, 2026, to develop and refine a behavioral sleep intervention for low-income families in pediatric primary care settings. Yale will adapt and test Sleep Well, Bee Well (SWBW), an evidence-based intervention grounded in social cognitive theory, for implementation in primary care offices serving low-income populations. The R61 phase (Year...
- The National Heart, Lung, and Blood Institute (NHLBI) awarded Boston Children's Hospital $171,600 on September 1, 2026, under CFDA 93.837 (Cardiovascular Diseases Research) to support career development and mentored research in pediatric obstructive sleep apnea diagnostics. The award funds the recipient investigator's training in three areas: predictive modeling and machine learning, advanced physiological signal analysis, and implementation science for translating research into clinical...
- The National Heart, Lung, and Blood Institute awarded the Research Foundation For Mental Hygiene, Inc., operating through its New York State Psychiatric Institute, $261,716 on July 22, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to adapt and pilot a doula-delivered cognitive behavioral therapy for insomnia (CBT-I) intervention for pregnant individuals experiencing prenatal sleep disturbances. The project addresses the gap between evidence-based CBT-I treatment efficacy...
- The National Institute of Mental Health awarded Emma Pendleton Bradley Hospital $398,669 on July 1, 2026, under the Mental Health Research Grants program (CFDA 93.242) to investigate the relationship between sleep disruption and psychosis-spectrum symptoms in adolescents aged 14–17 years. The research addresses three mechanistic gaps in the literature: the absence of dense sampling across days to measure temporal fluctuations between psychosis-spectrum symptoms and sleep in youth; reliance on...
- The National Heart, Lung, and Blood Institute awarded Brigham & Women's Hospital Inc. $353,776 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 20, 2025. The award funds investigation of place-based factors contributing to sleep health disparities in the United States. The research links nationwide public health surveillance data to neighborhood-level factors using geographic information science to test whether individual-level and place-based factors...
- The National Heart, Lung, and Blood Institute awarded the University of Pittsburgh $238,500 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to characterize sleep-related threat, a novel risk factor for sleep disturbances in intimate partner violence survivors. The project, funded as an R03 award, will define sleep-related threat—the development of cognitions and strategies to maintain wakefulness for self-protection—and identify initial links between this...
- The National Institute of Child Health and Human Development awarded Children's Research Institute $500,500 on September 1, 2026, under the Child Health and Human Development Extramural Research program (CFDA 93.HDR) to conduct a prospective observational study integrating bedside sleep monitoring tools for preterm infants during the neonatal intensive care unit (NICU) stay. The research addresses sleep-cycle maturation in preterm infants born during the extrauterine third trimester. Sleep...
- The National Heart, Lung, and Blood Institute awarded Seattle Children's Hospital $1,736,235 on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate sleep health and its relationship to childhood systemic lupus erythematosus (CSLE) symptoms within the sociocultural and neighborhood contexts of affected youth. The research examines associations between sleep health dimensions—including duration, efficiency, regularity, and daytime sleepiness—and CSLE...
- The National Heart, Lung, and Blood Institute awarded Emory University $100,228 on September 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct longitudinal research examining associations between sleep health, protective factors against psychosocial adversity, and stress-related biomarkers including allostatic load and epigenetic age acceleration. The project analyzes multidimensional sleep health—encompassing regularity, satisfaction, alertness, timing,...